Showing results (1-10 of 686) with videos related to
Sort By:
Pageof 69
Immunity|January 29, 2013
What mAbs tell us about shapes: multiple roads lead to RomeGalit Alter, Margaret E AckermanTrends in Immunology|August 19, 2014
An antibody tag-team: driving neutralization through escapeGalit Alter, Margaret E AckermanCurrent HIV Research|November 7, 2013
Opportunities to exploit non-neutralizing HIV-specific antibody activityMargaret E Ackerman, Galit AlterAnnual Review of Medicine|November 15, 2011
Emerging concepts on the role of innate immunity in the prevention and control of HIV infectionMargaret E Ackerman, Anne-Sophie Dugast, Galit AlterCurrent Opinion in HIV and AIDS|February 21, 2015
Prospects for engineering HIV-specific antibodies for enhanced effector function and half-lifeAustin W Boesch, Galit Alter, Margaret E AckermanImmunological Reviews|January 31, 2017
Systems serology for evaluation of HIV vaccine trialsMargaret E Ackerman, Dan H Barouch, Galit AlterJournal of Visualized Experiments : Jove|December 7, 2011
Determining the phagocytic activity of clinical antibody samplesElizabeth G McAndrew, Anne-Sophie Dugast, Anna F Licht, et al.Journal of Immunological Methods|October 2, 2012
High-throughput, multiplexed IgG subclassing of antigen-specific antibodies from clinical samplesEric P Brown, Anna F Licht, Anne-Sophie Dugast, et al.Journal of Virology|March 8, 2013
Enhanced phagocytic activity of HIV-specific antibodies correlates with natural production of immunoglobulins with skewed affinity for FcγR2a and FcγR2bMargaret E Ackerman, Anne-Sophie Dugast, Elizabeth G McAndrew, et al.Journal of Virology|December 20, 2013
Divergent antibody subclass and specificity profiles but not protective HLA-B alleles are associated with variable antibody effector function among HIV-1 controllersJennifer I Lai, Anna F Licht, Anne-Sophie Dugast, et al.Pageof 69